Stock listing

OTC:MTST Metastat Inc Stock

Follow Metastat Inc into a list and get an email when it puts out news.

Share price · OTC:MTST

$0.0010 USD 0.0000 (0.0%)

Close on Oct 13, 2026 · Data provided by Twelve Data

Metastat Inc logo
Ticker
OTC:MTST
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations

Jul 16, 2018

MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer

Jun 21, 2018

MetaStat Announces Positive Topline Data Showing Over 50% Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway

Feb 28, 2018

MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations

Sep 25, 2017

MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board

Aug 3, 2017

Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination and Metastasis in a Mena-dependent Manner

Jul 19, 2017

MetaStat Closes First Round of a $7 Million Private Placement

Jun 27, 2017

MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene Corporation

Jun 19, 2017

MetaStat Expands Therapeutic and Companion Diagnostic Intellectual Property Portfolio

May 23, 2017

MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors

May 8, 2017

All Metastat Inc news

Decks

Metastat Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in all · newest Jul 16, 2018 · oldest 2015
Decks
6 decks · latest Dec 4, 2015

Log in to ask 6ix AI your own questions about Metastat Inc.